US Patent Issued to Suzhou Genhouse Pharmaceutical on June 24 for "Pyrazine derivative and application thereof in inhibiting SHP2" (Chinese Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,246, issued on June 24, was assigned to Suzhou Genhouse Pharmaceutical Co. Ltd. (Suzhou, China).

"Pyrazine derivative and application thereof in inhibiting SHP2" was invented by Haifeng Sun (Suzhou, China), Kuifeng Wang (Suzhou, China), Tao Zhang (Suzhou, China), Mengnan Ma (Suzhou, China) and Jinchang Lu (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pyrazine derivative, an application thereof in inhibiting SHP2, and a compound of formula (I) or pharmaceutically acceptable salts, esters, isomers, solvates, prodrugs or isotope labels thereof. The structure of the compound of formula (I) is as follows...